Your browser doesn't support javascript.
loading
Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.
Borek, Bartlomiej; Nowicka, Julita; Gzik, Anna; Dziegielewski, Marek; Jedrzejczak, Karol; Brzezinska, Joanna; Grzybowski, Marcin; Stanczak, Paulina; Pomper, Paulina; Zagozdzon, Agnieszka; Rejczak, Tomasz; Matyszewski, Krzysztof; Golebiowski, Adam; Olczak, Jacek; Lisiecki, Kamil; Tyszkiewicz, Magdalena; Kania, Magdalena; Piasecka, Sylwia; Cabaj, Anna; Dera, Paulina; Mulewski, Krzysztof; Chrzanowski, Jacek; Kusmirek, Damian; Sobolewska, Elzbieta; Magdycz, Marta; Mucha, Lukasz; Masnyk, Marek; Golab, Jakub; Nowotny, Marcin; Nowak, Elzbieta; Napiorkowska-Gromadzka, Agnieszka; Pikul, Stanislaw; Jazwiec, Radoslaw; Dzwonek, Karolina; Dobrzanski, Pawel; Meyring, Michael; Skowronek, Krzysztof; Iwanowski, Piotr; Zaslona, Zbigniew; Blaszczyk, Roman.
  • Borek B; Molecure S.A., Warsaw, Poland.
  • Nowicka J; Molecure S.A., Warsaw, Poland.
  • Gzik A; Molecure S.A., Warsaw, Poland.
  • Dziegielewski M; Molecure S.A., Warsaw, Poland.
  • Jedrzejczak K; Molecure S.A., Warsaw, Poland.
  • Brzezinska J; Molecure S.A., Warsaw, Poland.
  • Grzybowski M; Molecure S.A., Warsaw, Poland.
  • Stanczak P; Molecure S.A., Warsaw, Poland.
  • Pomper P; Molecure S.A., Warsaw, Poland.
  • Zagozdzon A; Molecure S.A., Warsaw, Poland.
  • Rejczak T; Molecure S.A., Warsaw, Poland.
  • Matyszewski K; Molecure S.A., Warsaw, Poland.
  • Golebiowski A; Molecure S.A., Warsaw, Poland.
  • Olczak J; Molecure S.A., Warsaw, Poland.
  • Lisiecki K; Molecure S.A., Warsaw, Poland.
  • Tyszkiewicz M; Molecure S.A., Warsaw, Poland.
  • Kania M; Molecure S.A., Warsaw, Poland.
  • Piasecka S; Molecure S.A., Warsaw, Poland.
  • Cabaj A; Molecure S.A., Warsaw, Poland.
  • Dera P; Molecure S.A., Warsaw, Poland.
  • Mulewski K; Molecure S.A., Warsaw, Poland.
  • Chrzanowski J; Molecure S.A., Warsaw, Poland.
  • Kusmirek D; Molecure S.A., Warsaw, Poland.
  • Sobolewska E; Molecure S.A., Warsaw, Poland.
  • Magdycz M; Molecure S.A., Warsaw, Poland.
  • Mucha L; Molecure S.A., Warsaw, Poland.
  • Masnyk M; Molecure S.A., Warsaw, Poland.
  • Golab J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Nowotny M; Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, Warsaw, Poland.
  • Nowak E; Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, Warsaw, Poland.
  • Napiorkowska-Gromadzka A; Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, Warsaw, Poland.
  • Pikul S; Molecure S.A., Warsaw, Poland.
  • Jazwiec R; Institute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw, Poland.
  • Dzwonek K; Molecure S.A., Warsaw, Poland.
  • Dobrzanski P; Molecure S.A., Warsaw, Poland.
  • Meyring M; Nuvisan GmbH, Grafing, Germany.
  • Skowronek K; Biophysics and Bioanalytics Facility, International Institute of Molecular and Cell Biology, Warsaw, Poland. (RRID:SCR_021630).
  • Iwanowski P; Molecure S.A., Warsaw, Poland.
  • Zaslona Z; Molecure S.A., Warsaw, Poland.
  • Blaszczyk R; Molecure S.A., Warsaw, Poland.
Mol Cancer Ther ; 22(7): 807-817, 2023 07 05.
Article en En | MEDLINE | ID: mdl-36939275
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Arginasa / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Arginasa / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article